Cheaper Ozempic arrives: Dr Reddy’s launches generic semaglutide after patent expiry21 Mar, 2026, 04.15 PM ISTWho will win India’s weight loss drug war: Wegovy, Mounjaro or Biocon?07 Jul, 2025, 06.22 PM ISTCorner Office Conversation: Nandini Piramal of Piramal Pharma & Arjun Juneja of Mankind Pharma24 Nov, 2025, 07.00 AM ISTAlibaba bids $1.5 billion for China grocer Pupu in Meituan fight
"We are all waiting" for final AAIB report on AI-171 crash: Civil Aviation Minister
'Reject political turncoats': Slogan of obscure party now welcoming TMC rebels
Sudip Bandyopadhyay bets on pharma, metals and select cyclicals as geopolitical risks ease
A history of Iran's nuclear programme and tensions with the US as an interim deal is reached
Silver and gold ETFs rally up to 8% as US-Iran peace deal boosts sentiment. Should you invest now?
Renault partners with Thales to develop military vehicle in new defence project
India, UK discuss collaboration in tech, research, startups
Oswal Pumps shares gain 6% on 63 MW rooftop solar project win, eyes Rs 500 crore revenue opportunity
How AI is quietly rewriting the rules of filmmaking
Hormuz halt forces Middle East trade into huge rewiring
Technology and liquidity are reshaping India's investment landscape: Kailash Kulkarni
Kerala launches free KSRTC travel scheme for women, transgender persons
Ashok Leyland, Tata Motors and other CV stocks soar up to 9%. What’s triggering the surge?
Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
Times Syndication Service